Fernández de Luco Julia, Recio-Balsells Alejandro I, Ghiano Diego G, Bortolotti Ana, Belardinelli Juán Manuel, Liu Nina, Hoffmann Pascal, Lherbet Christian, Tonge Peter J, Tekwani Babu, Morbidoni Héctor R, Labadie Guillermo R
Instituto de Química Rosario, UNR, CONICET Suipacha 531 S2002LRK Rosario Argentina
Laboratorio de Microbiología Molecular, Facultad de Ciencias Médicas, Universidad Nacional de Rosario Santa Fe 3100 S2002KTR Rosario Argentina
RSC Med Chem. 2020 Nov 5;12(1):120-128. doi: 10.1039/d0md00291g. eCollection 2021 Jan 1.
Triclosan and isoniazid are known antitubercular compounds that have proven to be also active against parasites. On these grounds, a collection of 37 diverse 1,2,3-triazoles based on the antitubercular molecules triclosan and 5-octyl-2-phenoxyphenol (8PP) were designed in search of novel structures with leishmanicidal activity and prepared using different alkynes and azides. The 37 compounds were assayed against , the etiological agent of leishmaniasis, yielding some analogs with activity at micromolar concentrations and against H37Rv resulting in scarce active compounds with an MIC of 20 μM. To study the mechanism of action of these catechols, we analyzed the inhibition activity of the library on the enoyl-ACP reductase (ENR) InhA, obtaining poor inhibition of the enzyme. The cytotoxicity against Vero cells was also tested, resulting in none of the compounds being cytotoxic at concentrations of up to 20 μM. Derivative could be considered a valuable starting point for future antileishmanial drug development. The validation of a putative leishmanial InhA orthologue as a therapeutic target needs to be further investigated.
三氯生和异烟肼是已知的抗结核化合物,已证明它们对寄生虫也有活性。基于此,设计了一组基于抗结核分子三氯生和5-辛基-2-苯氧基苯酚(8PP)的37种不同的1,2,3-三唑,以寻找具有杀利什曼原虫活性的新结构,并使用不同的炔烃和叠氮化物进行制备。对这37种化合物针对利什曼病的病原体进行了检测,得到了一些在微摩尔浓度下具有活性的类似物,而针对H37Rv的检测结果显示,活性化合物稀缺,其最低抑菌浓度为20μM。为了研究这些儿茶酚的作用机制,我们分析了该文库对烯酰-ACP还原酶(ENR)InhA的抑制活性,结果显示对该酶的抑制作用较差。还测试了对Vero细胞的细胞毒性,结果表明在浓度高达20μM时,没有一种化合物具有细胞毒性。衍生物可被视为未来抗利什曼原虫药物开发的一个有价值的起点。作为治疗靶点的假定利什曼原虫InhA同源物的验证需要进一步研究。